The shortage of injectable opioids is reaching critical levels in hospitals nationwide and leaving health system pharmacists scrambling to find alternative treatment options for patients.
Megan Rech, PharmD, discusses the impact of using intranasal administration of medications in the ED.
A nonsteroidal anti-inflammatory drug has been subject to a Class II recall by the FDA.
Almost 578,800 bags of a drug used for patients with a variety of anaerobic infections has been recalled due to sterility issues.
Jeremy Theal, MD, discussed how a health information system initiative at his hospital helped to significantly reduce adverse drug events and medication errors.